372 related articles for article (PubMed ID: 32777129)
1. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
[TBL] [Abstract][Full Text] [Related]
2. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
Rowniak S; Bolt L; Sharifi C
JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
[TBL] [Abstract][Full Text] [Related]
3. Gender minority stress in transgender people: a major role for social network.
Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
[TBL] [Abstract][Full Text] [Related]
4. Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment.
Mazzoli F; Cassioli E; Ristori J; Castellini G; Rossi E; Cocchetti C; Romani A; Angotti T; Giovanardi G; Mosconi M; Lingiardi V; Speranza AM; Ricca V; Vignozzi L; Maggi M; Fisher AD
J Endocrinol Invest; 2022 Nov; 45(11):2059-2068. PubMed ID: 35779204
[TBL] [Abstract][Full Text] [Related]
5. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
6. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
8. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
9. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
11. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
[TBL] [Abstract][Full Text] [Related]
12. A Longitudinal Study Exploring the Role of Mental Health Symptoms and Social Support Regarding Life Satisfaction 18 Months after Initiation of Gender-Affirming Hormone Treatment.
Aldridge Z; Thorne N; Bouman WP; Witcomb GL; Arcelus J
Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766954
[TBL] [Abstract][Full Text] [Related]
13. Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care.
Tordoff DM; Wanta JW; Collin A; Stepney C; Inwards-Breland DJ; Ahrens K
JAMA Netw Open; 2022 Feb; 5(2):e220978. PubMed ID: 35212746
[TBL] [Abstract][Full Text] [Related]
14. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
[TBL] [Abstract][Full Text] [Related]
15. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
16. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
17. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
Ong C; Monita M; Liu M
Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
[TBL] [Abstract][Full Text] [Related]
18. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
J Sex Med; 2022 Jul; 19(7):1173-1184. PubMed ID: 35418328
[TBL] [Abstract][Full Text] [Related]
19. [Psychosocial assessment in transgender adolescents].
López de Lara D; Pérez Rodríguez O; Cuellar Flores I; Pedreira Masa JL; Campos-Muñoz L; Cuesta Hernández M; Ramos Amador JT
An Pediatr (Engl Ed); 2020 Jul; 93(1):41-48. PubMed ID: 32144041
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
